Newsroom
March 14, 2023
Montaser Shaheen, MD, Hematology & Oncology, The UT Health San Antonio Mays Cancer Center, was interviewed for this news segment about the results of a phase II clinical trial showing participants with stage III and IV melanoma who received treatment before and after surgery, had significantly lower risks of cancer. Watch Now
March 13, 2023
Mays Cancer Center at UT Health San Antonio melanoma expert Monte Shaheen, MD, was part of a team of investigators that conducted a phase II clinical trial to determine the efficacy and safety of administering the immunotherapy drug pembrolizumab before and after surgery in high-risk melanoma patients.
March 6, 2023
Amelie Ramirez, DrPH, MPH, leader of Salud America! at UT Health San Antonio, is among 15 new inductees to the San Antonio Women’s Hall of Fame. The San Antonio Women’s Hall of Fame has annually inducted women from Bexar and surrounding counties who have shaped the future of San Antonio and paved the way for women […]
March 1, 2023
Randy Wright, MD, Medicine/Gastroenterology, was interviewed for this news segment. Watch Now
February 28, 2023
The University of Texas Health Science Center was mentioned in this story. Read More
February 28, 2023
The University of Texas Health Science Center San Antonio was mentioned in this story. Read More